Highlights d Autophagy induction in hippocampal neurons is required to promote memory formation d Hippocampal autophagy induction enhances activitydependent synaptic plasticity d Inducing autophagy in old hippocampi is sufficient to reverse age-impaired memory d Autophagy integrates the effects of youthful systemic factors in the aged brain
In Brief
Glatigny et al. show that autophagy induction in hippocampal neurons enhances cognition by promoting memory formation and integrating the effects of youthful systemic factors. During aging, hippocampal autophagy is reduced and its induction is sufficient to improve age-impaired memory.
SUMMARY
Age-related declines in cognitive fitness are associated with a reduction in autophagy, an intracellular lysosomal catabolic process that regulates protein homeostasis and organelle turnover. However, the functional significance of autophagy in regulating cognitive function and its decline during aging remains largely elusive. Here, we show that stimulating memory upregulates autophagy in the hippocampus. Using hippocampal injections of genetic and pharmacological modulators of autophagy, we find that inducing autophagy in hippocampal neurons is required to form novel memory by promoting activity-dependent structural and functional synaptic plasticity, including dendritic spine formation, neuronal facilitation, and longterm potentiation. We show that hippocampal autophagy activity is reduced during aging and that restoring its levels is sufficient to reverse age-related memory deficits. Moreover, we demonstrate that systemic administration of young plasma into aged mice rejuvenates memory in an autophagy-dependent manner, suggesting a prominent role for autophagy to favor the communication between systemic factors and neurons in fostering cognition. Among these youthful factors, we identify osteocalcin, a bone-derived molecule, as a direct hormonal inducer of hippocampal autophagy. Our results reveal that inducing autophagy in hippocampal neurons is a necessary mechanism to enhance the integration of novel stimulations of memory and to promote the influence of systemic factors on cognitive fitness. We also demonstrate the potential therapeutic benefits of modulating INTRODUCTION In the mammalian brain, the hippocampus is pivotal for the control of learning and memory. The formation and consolidation of memory relies on the capacity of the hippocampus to integrate novel stimuli through neuronal structural reorganization and plasticity [1] [2] [3] [4] . In hippocampal neurons, autophagosomes (APs), double-membraned vesicles involved in autophagy, have been shown to actively form in synapses and along neuronal processes [5] [6] [7] , and emerging data suggest that hippocampal autophagy may contribute to neuronal homeostasis, playing a role in synaptic assembly, axonal growth, dopamine release, and long-term depression (LTD) [5] [6] [7] [8] [9] [10] .
Autophagy is a cellular catabolic process whereby proteins and organelles are engulfed in APs and then transported to lysosomes for degradation [11, 12] . The biogenesis of APs is orchestrated by multiple ATG (autophagy-related) proteins (such as beclin 1, Fip200, and VPS34) that are engaged in different dynamic membrane complexes [13] [14] [15] . The ATG5/12/16L1 complex finally allows for lipidation of the LC3 protein (LC3-II), which is then recruited to the site(s) of nascent APs to favor the maturation of the AP [13] [14] [15] . Beyond its basal functions, autophagy can be stimulated by various physiological stimuli and changes in environmental conditions [12] . There is now increasing evidence that autophagy induction is essential to control important physiological functions, such as regulation of energy metabolism, control of appetite, and modulation of host defenses, by mediating the cellular adaptive responses to novel physiological stimuli [12, 16, 17] . However, the role of this stimulated autophagy remains largely elusive in the brain. The fact that memory and neuronal plasticity in the hippocampus undergo changes in cellular protein homeostasis and organelle turnover [1, 18] and that hippocampal neurons are constantly subjected to novel stimuli and modulated by environmental factors leads us to hypothesize that autophagy has an important functional role in regulating hippocampal-dependent cognitive fitness. Importantly, the hippocampus is highly vulnerable to aging, exhibiting alterations in functional synaptic plasticity and progressive impairments in associated learning and memory [4, [19] [20] [21] [22] [23] . Given the current increase in life expectancy, the number of individuals affected by age-related memory loss is bound to dramatically increase and represents an unmet medical need [1, 24] . Recent progress has demonstrated the potential therapeutic effects of exposure to a ''young'' systemic milieu in preventing and/or reversing aging-associated memory decline, pointing to the importance of systemic circulating factors in the control of hippocampal cognitive fitness [25] [26] [27] [28] ; however, the mechanisms mediating this phenomenon in neurons are still poorly understood. Therefore, identification of intracellular mechanisms favoring neuronal plasticity and memory in the hippocampus is important in understanding how cognition and memory are affected during aging. Interestingly, the age-related decline in hippocampal-dependent memory is commonly associated with a reduction of ATG proteins in various tissues, including brain in which Atg5, Atg7, and Becn 1 are found to be downregulated [29] [30] [31] .
Given the above observations, we set out to determine the functional significance of autophagy in hippocampal-dependent cognitive fitness and to elucidate whether age-impaired autophagy in the brain is directly responsible for hippocampaldependent memory deficits. We show that memory-related stimulations enhance autophagy activity in mouse hippocampi and that this induction is required to form novel memory by promoting the activity-dependent synaptic plasticity in hippocampal neurons. Furthermore, we show that autophagy activity is reduced in old hippocampi and that restoring its level fully reverses associative and spatial memory deficits in aged mice. In addition, we show that autophagy is induced in hippocampal neurons by exposure to a young systemic milieu and identify osteocalcin (Ocn) as one such circulating factor in young plasma. Together, these data demonstrate that the activation of autophagy by novel stimulations is necessary to promote the capac-ity of hippocampal neurons to form new memories and that young circulating factors improve cognitive performance in aged mice by inducing autophagy in the hippocampus. These results demonstrate the potential therapeutic benefits of promoting autophagy in aged brains to reverse and/or prevent the effects of aging on cognitive functions.
RESULTS

Hippocampal Autophagy Is Upregulated by Novel Stimulations of Memory
We first observed that exposing 3-month-old mice to novel memory-related stimulations, induced by contextual fear conditioning (CFC), enhanced the expression of key ATGs (beclin 1, VPS34, and ATG5) at both the mRNA and protein level in the hippocampus, and this upregulation was proportional to the level of stimulation ( Figures 1A, 1B , and S1A). Similar results were obtained after exposing mice to Morris water maze tasks (MWM) ( Figure S1C ). Moreover, the increase in LC3-I conversion to LC3-II (AP formation marker) together with a decrease in SQSTM1/p62 (an AP cargo protein degraded after fusion with the lysosome) demonstrates that novel memory stimulations enhanced autophagic flux in the hippocampus ( Figures  1A, 1C , S1B, S1D, and S1E). Although we cannot exclude that training itself induces autophagy in the hippocampal region of the brain, the fact that our control mice were subjected to the same context but without exposure to the memory paradigm indicates that novel memory-related stimulations induce hippocampal autophagy. Moreover, neither CFC nor MWM stimulations affect LC3-II abundance in the cerebellum (a brain region not directly implicated in the control of memory functions; Figures S1F and S1G). Lastly, exposing mice to acute restraint stress did not induce any modifications in hippocampal autophagy as seen after CFC or MWM ( Figure S1H ). Together, these data indicate that memory-related stimulations upregulate hippocampal autophagy and strongly suggest that autophagy plays a role in the regulation of learning and memory in the hippocampus.
Figure 1. Autophagy Is Upregulated in the Hippocampus by Novel Memory Stimuli and Promotes Learning and Memory
(A and B) VPS34, beclin 1, ATG5, LC3-I, and LC3-II accumulation (A; representative western blot) and Vps34, Beclin 1 (Becn 1), and Atg5 expression (B; qPCR performed in triplicate for each sample) in hippocampi of 3-month-old WT mice exposed to 1 (1dS) or 4 (4dS) consecutive days of memory-related stimulations induced by 3-foot-shock CFC. The hippocampi were collected 1 hr after the first (1dS; n = 7) or 1 hr after the last (4dS; n = 4-7) memory-related stimulation. The results are represented in comparison to 3-month-old WT mice exposed to the same context but without memory paradigm (NS; n = 5 or 6). b-actin was used as a loading control for each sample. Quantification of mRNA expression is relative to the NS group. These measurements were performed in two independent experiments for (A) and (B). See also Figure S1 . (C) SQSTM1/p62 immunofluorescence (scale bars represent 20 mm) performed on brain cross-sections at the level of the hippocampal dentate gyrus (DG) (n = 4) and CA3 regions (n = 6) in 3-month-old WT mice after 4dS of memory-related stimulation compared to the NS group. Brains were collected from two independent cohorts of mice for each group. See also Figure S1 . (D) LC3-I and LC3-II accumulation and LC3-II/b-actin ratio quantification in mouse hippocampi 3 weeks after stereotactic injections with either AAV-Fip200-shRNA (n = 3), AAV-Beclin 1-shRNA (n = 4), AAV-Atg12-shRNA (n = 3), or their respective AAV-Scramble-shRNA (n = 3 or 4). The quantification is relative to mice injected with AAV-Scramble. These measurements were obtained from 3 independent experiments for each group and its respective control. See also Figure S2 . (E) Novel object recognition (NOR) performed in 3-month-old mice 3 weeks after hippocampal stereotactic injections with either AAV-Fip200-shRNA (n = 14), AAV-Beclin 1-shRNA (n = 14), AAV-Atg12-shRNA (n = 14), or their AAV-Scramble-shRNA (n R 10). Discrimination index was measured 24 hr after the training phase to assess memory performances. The NOR was performed in two independent experiments for each group and its respective control. See also Figure S2 . (F) 3-foot-shock contextual fear conditioning (CFC) performed in 3-month-old mice 3 weeks after stereotactic injections with either AAV-Fip200-shRNA (n = 12), AAV-Beclin 1-shRNA (n = 14), AAV-Atg12-shRNA (n = 12), or their AAV-Scramble-shRNA (n R 10). Percent freezing was measured for the training (as a control for the basal level of mouse freezing) and testing phases (to assess memory performances). The CFC was performed in two independent experiments for each group and its respective control. Independent cohorts of mice were used for each behavioral test (no mice were used in more than one behavioral test). Data are expressed as mean ± SEM. *p % 0.05; **p % 0.01; ***p % 0.001; NS, not significant, by Student's t test compared to the control group. (A) The construct expresses eGFP, which allows for verification of the site and efficacy of infection. The left panel is a panoramic photo of an entire brain region obtained by automatically aligning and stitching 54 tiled images into a mosaic (using the Zen Light Zeiss LSM software package). A focus was made on the Dentate Gyrus (DG), CA3 and CA1 regions of the hippocampus (right images). (B) LC3 Immunofluorescence (Scale bar = 20mm) performed at the level of the dentate gyrus (DG) and CA3 of the hippocampus. The analysis was performed on n = 6 animals for each group derived from two independent cohorts of mice. (C) NOR performed in 3-month-old mice, 3 weeks after hippocampal stereotactic injections with either AAV-eSYN-Beclin 1-shRNAmir (n = 10) or AAV-Scramble-shRNAmir (n = 10). Discrimination (3 rd panel) and preference indexes (4 th panel) were measured 24 hr after the training phase to assess memory performances. As control, preference index for the (right versus left) object location (1 st panel) or for the object A versus B (2 nd panel) during the training phase of the NOR was measured. We confirm that no initial preference for any exposed object (A or B) or any orientation (right versus left) was observed in any group. We also quantified the locomotion by measuring the distance (meter) traveled by each mouse group during the testing phase (5 th panel), and no differences were observed. The NOR was performed in two independent experiments for each group and its respective control.
(legend continued on next page)
Neuronal Autophagy Influences Hippocampal-Dependent Memory Performances
To further investigate the functional significance of memoryinduced autophagy, we generated mouse models to selectively downregulate hippocampal autophagy by performing stereotactic injections of adeno-associated viruses (AAV) expressing short hairpin RNAs (shRNAs) against Fip200, Beclin 1, or Atg12, major genes involved in distinct dynamic membrane complexes controlling different steps of AP biogenesis [14] [15] [16] . A decrease in the abundance of LC3-II and an increase of SQSTM1/p62 accumulation, observed 3 weeks after injections of each AAV, confirmed that autophagy was significantly hampered in the hippocampus ( Figures 1D and S2A-S2H ). Mice were then subjected to two independent behavioral tasks to assess hippocampaldependent learning and memory [32] : the novel object recognition (NOR) test (Figures 1E and S2I-S2K) and the 3-foot-shocks CFC paradigm ( Figure 1F ). Both tests assess associative memory and rely on two phases: a training phase, in which mice are exposed to novel memory stimulations (NOR: exposure to two similar objects; CFC: 3 foot-shocks associated to a neutral environment) and a testing phase performed 24 hr after the training phase, in which memory performances are evaluated (NOR: recognition of a novel exposed object; CFC: measurement of context-elicited freezing). In NOR, we found that the downregulation of either Fip200, Beclin 1, or Atg12 severely impaired memory capacities as demonstrated by a drastic decrease in the time exploring a novel object compared to control mice ( Figures 1E and S2I-S2K). We next confirmed these results in CFC by showing that all mice downregulated for autophagy exhibited a decrease in freezing in contextual memory testing ( Figure 1F ). Importantly, the downregulation of Beclin 1 selectively in hippocampal neurons, obtained after stereotactic AAV injections of a neuronal synapsin 1 promoter-driven shRNA for Beclin 1 (eSYN-Beclin 1-shRNAmir) (Figures 2A and 2B ), leads to similar memory deficits in NOR ( Figure 2C ) and CFC ( Figure 2D ) tests. Importantly, these mutant mice and their controls showed comparable performances in the open field (OFT) and rotarod tests, indicating that their locomotor functions and anxiety state were unaffected ( Figures 2E and 2F ).
Stimulation-Induced Autophagy in the Hippocampus Is Necessary to Form New Memories
The above results demonstrate that reducing autophagy in the hippocampus impairs cognitive fitness. As autophagy is acutely upregulated during exposure to novel memory-related stimuli, we hypothesized that autophagy plays a role specifically during novel stimulations in hippocampal neurons and consequently contributes to the formation of new memories. Therefore, we acutely targeted hippocampal autophagy during exposure to novel stimulations (training phase) or after the training phase by performing single hippocampal stereotactic injections of pharmacological inhibitors of autophagy using spautin-1 (specific autophagy inhibitor-1, which interferes with AP formation) or by blocking the late stages of the autophagic pathway by using leupeptin or chloroquine ( Figures 3A and S3A and S4D-S4F). Importantly, modulating autophagy 12 hr after exposure to novel stimulations with either spautin-1, leupeptin, or TAT-beclin 1 ( Figure 3E ) did not influence memory performances in both tests ( Figures 3F, 3G , S4G, and S4H), showing that stimulation-induced autophagy in the hippocampus is specifically required during the formation of novel memories.
Stimulation-Induced Autophagy Enhances Activity-Dependent Structural and Functional Synaptic Plasticity in Hippocampal Neurons
In order to gain insight into the neuronal consequences of hippocampal stimulation on autophagy, we isolated primary hippocampal neurons from mice and subjected them to stimulation by chemical depolarization with potassium chloride (KCl) or chemical long-term potentiation (cLTP), a putative functional correlate of learning and memory that has been shown to induce synaptic plasticity [34, 35] . As shown in Figure 4A , both KCl and cLTP treatments enhanced AP formation as determined by measuring LC3-II levels. In addition, as previously described [34, 35] , we observed that cLTP treatment also increased dendritic spine formation and enhanced GluA1 and CAMKIIa phosphorylation, markers of increased synaptic strength ( Figures 4C  and 4D ). Therefore, we next investigated whether downregulation of autophagy affected these structural and molecular changes. We observed that the acute downregulation of Beclin 1 in primary hippocampal neurons ( Figure 4B ) blocks the formation of novel dendritic spines and phosphorylation of GluA1 and (D) CFC performed in 3-month-old mice 3 weeks after stereotactic injections with either AAV-eSYN-Beclin 1-shRNAmir (n = 10) or AAV-Scramble-shRNAmir (n = 10). Percent freezing was measured for the training and testing phases. The CFC was performed in two independent experiments for each group and its respective control. (E) Open field test (OFT) performed in 3 month old, 3 weeks after hippocampal stereotactic injections with either AAV-eSYN-Beclin 1-shRNAmir (n = 10) or AAV-Scramble-shRNAmir (n = 10). Total ambulation (meter), distance and time spent in the center of the arena (%), and speed (cm/s) were measured. This analysis was performed on 1 cohort of mice for each group.
(F) Rotarod test performed in 3 month old, 3 weeks after hippocampal stereotactic injections with either AAV-eSYN-Beclin 1-shRNAmir (n = 10) or AAV-Scramble-shRNAmir (n = 10). Values represent mean latency to fall during the 10 acquisition trials performed over 2 days (5 trials/day). This analysis was performed on 1 cohort of mice for each group. Independent cohorts of mice were used for each behavioral test (no mice were used in more than one behavioral test , TAT-beclin 1 (n = 13 or 12), or their respective vehicle (n R 8). For NOR, the discrimination index was measured for each group during the testing phase. For CFC, percent freezing was measured for each group during the training phase and testing phases to assess memory performances. The CFC was performed in two independent experiments for each treatment and its respective control. The NOR was performed on one cohort of mice for each treatment and its respective control. See also Figure S4 .
(E-G) Schematic representation of the experimental procedure to induce a modulation of autophagy after the acquisition phase (E). 12 hr after training phase, mice were injected in the hippocampus with either spautin-1 (n = 7-13), leupeptin (n = 6-14), TAT-beclin 1 (n = 7-13), or their respective vehicle (n R 6). Mice were then subjected, 12 hr later, to the testing phase of either NOR (F) or CFC (G). For NOR, the discrimination index was measured for each group during the testing phase. For CFC, percent freezing was measured for each group during the training and testing phases. The CFC was performed in two independent experiments for each treatment and its respective control. The NOR was performed on one cohort of mice for each treatment and its respective control. See also Figure S4 . Independent cohorts of mice were used for each behavioral test (no mice were used in more than one behavioral test). Data are expressed as mean ± SEM. *p % 0.05; **p % 0.01; ***p % 0.001; NS, not significant by Student's t test compare to WT mice injected with vehicle and (TAT-Beclin injections) by two-way ANOVA repeated-measure followed by a post hoc Tuckey's honestly significant difference (HSD) multiple comparisons test for pairwise differences between each group of mice. (F) Basic synaptic transmission. The input-output curves were generated by computing stimulation intensity against field EPSP slope in control slices versus slices exposed to spautin-1 at 10 mM. Data were obtained on 7 slices from n = 4 mice in the control condition and 6 slices from n = 3 mice after spautin-1 treatment). I/O curves revealed no differences between the 2 groups of slices (p = 0.78).
(G) Paired pulse facilitation (PPF) of synaptic transmission. Data were obtained from 8 control slices from n = 4 mice and 8 spautin-1 treated slices from n = 4 mice. PPF was significantly decreased in slices treated with spautin-1 at 10 mM (p = 0.017; Mann-Whitney test).
(H) Long-term potentiation of synaptic transmission. Data were obtained from 7 control slices from n = 7 mice and 7 spautin-1 exposed slices from n = 4 mice. Representative traces from one experiment are shown on the top of the graph. Results show a significant decrease of LTP in slices perfused with spautin-1 at (legend continued on next page) CAMKIIa after cLTP treatment ( Figures 4C and 4D ), suggesting that autophagy induction is required to enhance the activitydependent plasticity changes in hippocampal neurons during stimulation. Importantly, without neuronal stimulations, acutely targeting autophagy does not alter baseline levels of dendritic spine density or synaptic plasticity markers. To corroborate these structural results in vivo, we assessed dendritic spine density in mice that were locally injected with either AAV-Beclin 1-shRNA or AAV-Scramble-shRNA and subjected to MWM tasks (for 5 consecutive days), which is known to enhance dendritic spines formation in granular neurons of the hippocampal dentate gyrus (DG) [36, 37] . Results from Golgi staining revealed a significant induction of dendritic spine formation in DG hippocampal granular neurons of control mice, but not in mice that were downregulated for Beclin 1 (Figure 4E ). We then assessed the effect of acute autophagy inhibition (after treatment with spautin-1) on basal glutamatergic transmission and on shortand long-term plasticity in wild-type (WT) hippocampal slices. As shown on Figure 4F , the basal glutamatergic neurotransmission, defined by input-output (I/O) curves, was not significantly affected by acute treatment with spautin-1. In contrast, we observed a significant and sustained reduction of the pairedpulse facilitation ratio (PPF) in the slices treated with spautin-1, demonstrating a strong alteration of short-term plasticity mechanisms by acute autophagy inhibition ( Figure 4G ). Similarly, treatment with spautin-1 induced a significant decrease in LTP amplitude ( Figure 4H ). Indeed, the mean values of the field excitatory postsynaptic potential (fEPSP) slopes (measured during 10 min before the end of recordings) were significantly decreased in slices exposed to spautin-1 (190.66% ± 15.07% in control condition compared to spautin-1 139.37% ± 13.19%). These data demonstrate that autophagy is required to promote both structural and functional (short-and longterm) synaptic plasticity in hippocampal neurons in response to novel neuronal stimulations.
Promoting Autophagy in Old Hippocampi Is Sufficient to Reverse Age-Impaired Memory Normal aging is characterized by a decline in hippocampal neuronal plasticity and increased memory impairments [4, [20] [21] [22] and is associated with a reduction of autophagy in various tissues [29] [30] [31] . In the hippocampi of 16-month-old mice, we observed a marked decrease in beclin 1, VPS34, and ATG5 at both the protein (Figures 5A and S5A ) and mRNA level ( Figure 5B ). Furthermore, a reduction in autophagy activity was observed, as demonstrated by a slight decrease in LC3-II accumulation ( Figure 5A ), together with an increase in SQSTM1/p62 levels ( Figures 5C and S5B ). Co-immunofluorescence analysis indicates that the increase in SQSTM1/p62 puncta accumulation is highly present in neurons (NeuN + cells) but also in some astrocytes (GFAP + cells), both in the DG and CA3 regions of old hippocampi ( Figure S5C ). These results prompted us to examine whether inducing autophagy in old hippocampi could improve age-impaired memory deficits observed in 16-month-old mice ( Figure 5D ). To that end, we subjected 3-or 16-month-old WT mice to object location memory (OLM) (assessing spatial memory; Figure S5D ), NOR ( Figures 5E and S5E ), and CFC ( Figure 5F ) tests after hippocampal stereotactic injections of TAT-beclin 1, TAT-Scramble, or vehicle. We observed that TAT-beclin 1 injections in 16-month-old animals induced autophagy and improved memory performances in all behavioral tests ( Figures 5E, 5F , S5D, and S5E). These results indicate that promoting autophagy in old hippocampi is sufficient to rejuvenate memory in aged animals and suggests that hippocampal and/or organism changes contribute to reduced autophagy in the brain during aging.
Young Plasma Injections Reverse Aged-Memory Deficits by Promoting Autophagy in Old Hippocampi
Recent studies have shown that repeated systemic administrations of young blood plasma into aged animals improved agerelated cognitive impairments by rehabilitating synaptic plasticity capacity [25] [26] [27] [28] . This led us to investigate whether autophagy promotes the beneficial effects of young plasma on memory decline in aged mice. We found that 16-month-old mice that received plasma collected from young (8-week-old) mice had an increase of LC3-II accumulation and a slight decrease of SQSTM1/p62 levels in comparison to old mice that received vehicle ( Figures 6A and S6A ). Conversely, we did not detect differences in aged mice treated with aged plasma (from 16-month-old mice; Figures 6A and S6A ). Subsequently, in an independent cohort of aged mice, we confirmed that systemic injections of young plasma reversed age-related memory deficits, but importantly, this reversal was not observed in 16-month-old animals in which Beclin 1 was downregulated ( Figures 6B and  S6B) . These data suggest that rejuvenating circulating factors present in young plasma ameliorate age-related memory deficits via restoring autophagy levels in old hippocampi.
Osteocalcin Is a Youthful Plasma Factor Inducing Hippocampal Autophagy in Old Mice Interestingly, Ocn was recently identified as a necessary circulating factor of young plasma, which can rejuvenate hippocampal-dependent memory functions in aged mice [28, 38] .
Ocn is a bone-derived hormone that crosses the bloodbrain barrier, that influences hippocampal-dependent memory through the activation of its receptor Gpr158 in hippocampal neurons [28, [38] [39] [40] [41] , and its circulating levels are drastically reduced during aging [41, 42] . Importantly, we observed that Ocn treatment in primary hippocampal neurons significantly enhances AP formation, as shown by measuring LC3-II levels in the presence and in the absence of lysosomal blockers (bafilomycin), respectively ( Figure 6C ). This observation together with the fact that restoring its levels in 16-month-old mice is sufficient to reverse age-related cognitive impairments [28] 6D and S6C ). Subsequently, we show that the contribution of Ocn is required to promote the effects of young plasma injections on age-impaired LC3-II levels. Indeed, injections of plasma from young WT mice immunodepleted for Ocn (90% of Ocn was reduced after immunodepletion; see STAR Methods) [28] failed to improve the decrease in LC3-II accumulation and the increase in SQSTM1/p62 levels in old mice to the same extent as the injections of young plasma control (treated with immunoglobulin G [IgG]; Figures 6E and S6D ). Finally, we confirmed that systemic infusions of exogenous Ocn in 16-month-old mice improved age-related memory deficits.
However, this Ocn-induced memory improvement was abolished in the hippocampal neurons of 16-month-old animals in which Beclin 1 had been selectively downregulated ( Figures  6F, S6E, and S6F) . These data support the necessary contribution of autophagy in promoting the beneficial effects of young circulating factors on age-related memory decline and identify Ocn as a direct hormonal inducer of autophagy in hippocampal neurons. In total, these results demonstrate the importance of inducible hippocampal autophagy for cognitive fitness, especially during aging.
DISCUSSION
The identification of intracellular cues in hippocampal neurons that control memory formation is of utmost importance in order to understand how cognition is regulated and how it is altered under pathological and aging conditions. We show that the stimulation of memory by behavioral tasks upregulates autophagy in the hippocampus and that learning and memory is dependent on induced autophagy activity in hippocampal neurons. Next, we demonstrate that memory is influenced if autophagy is modulated during the training phases of behavioral tasks, when animals are exposed to novel stimulations. This suggests that neuronal stimulation induces an autophagic response that allows neurons in the hippocampus to incorporate these stimuli by promoting the formation of dendritic spines and increased synaptic strength. It is still unclear how neuronal stimulation induces an increase in autophagy levels; however, these results reveal an important physiological function of autophagy in the brain beyond its known cellular roles in housekeeping pathways. Our findings suggest autophagy promotes memory formation by modulating the adaptive responses of hippocampal neurons to novel stimuli. Mechanistically, we show that autophagy induction is required for shaping activity-dependent synaptic plasticity in hippocampal neurons, including the enhancement of dendritic spine formation and synaptic molecular strength after stimulations. Nevertheless, our investigation did not allow us to determine dendritic spine type and morphology or whether these defects predominantly concern a specific neuronal population in the hippocampus. Electrophysiological analyses of brain slices following acute hippocampal autophagy inhibition suggested that basal neurotransmission was not affected. However, our data show a significant reduction in the amplitude of the field EPSP following LTP stimulation. This observation suggests that hippocampal autophagy is important for promoting longterm synaptic plasticity. Interestingly, age-dependent alterations in the induction of LTP are well documented [4] . Moreover, our electrophysiological findings also demonstrate that inhibiting autophagy acutely on hippocampal slices also induced a sustained reduction of the neuronal facilitation, namely PPF, a form of short-term activity-dependent synaptic plasticity. Changes in PPF observed after autophagy inhibition suggest a presynaptic involvement of autophagy in hippocampal neurons. Importantly, these findings can be corroborated with recent reports showing that presynaptic domains are active sites for AP biogenesis [5-7, 43, 44] , suggesting an intimate dialogue between presynaptic domains and autophagy machinery. Finally, defects in neuronal facilitation may also contribute to postsynaptic alterations (i.e., a decrease in LTP amplitude). Together, these findings indicate that acute downregulation of hippocampal autophagy does not affect basal neurotransmission but reduces both short-and long-term activity-dependent synaptic plasticity capacity in hippocampal neurons in response to novel neuronal stimuli.
The selective downregulation of beclin 1 in hippocampal neurons and primary hippocampal neuronal cultures demonstrates the important role of neuronal autophagy in regulating memory and hippocampal synaptic plasticity. Although our study focuses on hippocampal neurons, we cannot exclude the possibility that autophagy activity in other hippocampal cell populations may also contribute to the regulation of memory formation and cognitive fitness. Indeed, the pharmacological targeting of autophagy after hippocampal injections does not selectively target neuronal autophagy, and other cell populations could also partially contribute to memory formation and age-impaired memory performances. Moreover, autophagy has been shown to play a role in other cell types, such as astrocytes that prune axons [45] and oligodendrocytes that increase myelination [46] . Therefore, further analyses will be required to determine the specific hippocampal neuronal populations and possibly other cell type(s) (i.e., astrocytes), in which autophagy has a predominant effect in the control of memory formation.
Aging is commonly associated with progressive impairments in hippocampal-dependent memory [19] [20] [21] [22] [23] [24] and with defective autophagy in various tissues [29] [30] [31] . We show that autophagy activity is reduced in the hippocampus during aging and that Figure S6 . (F) NOR performed in 3-(n = 8) and 16-month-old mice (n = 7-9), after hippocampal stereotactic injections of either AAV-eSYN-Beclin 1-shRNAmir or AAV-Scramble-shRNA and infused peripherally and continuously through minipumps with uncarboxylated Ocn (30 ng/hr) or vehicle (NaCl). Discrimination index and preference index were measured for each group during the testing phase. The NOR was performed in two independent experiments for each group of mice. See also Figure S6 . Independent cohorts of mice were used for each behavioral test (no mice were used in more than one behavioral test). All behavioral tests were performed on n R 7 mice per group. Data are expressed as mean ± SEM. *p % 0.05; **p % 0.01; ***p % 0.001; NS, not significant by Student's t test and by one-way ANOVA followed by a post hoc Tuckey's HSD multiple comparisons test for pairwise differences between each group of mice. promoting autophagy in old hippocampi is necessary and sufficient to improve age-related hippocampal-dependent memory deficiencies. These results reinforce the link between autophagy and aging and underscore the importance of maintaining autophagy capacity in the brain for cognitive fitness throughout life. This has important clinical implications in preventing and/or treating cognitive impairments in aging populations, as autophagy is directly targetable by drugs [47] , and its pharmacological induction could be amenable to significant therapeutic benefits [48, 49] . It is important to note that, during brain aging, the alterations in dendritic spines formation are subtle and region specific [4] . Consequently, the influence of autophagy on dendritic spine formation may not be directly related to its beneficial effects on age-related cognitive deficits. However, our demonstration that autophagy is required for activity-dependent dendritic spine formation may help to partially modulate mechanisms of plasticity that could be affected in various cognitive disorders. Moreover, the decrease in autophagy activity observed in old hippocampi is not restricted to neurons, but it is also present in some astrocytes, both in the CA3 and DG regions. This suggests a possible role for autophagy in astrocytes in ageimpaired memory and brain aging processes.
Perhaps the most intriguing finding of our study is the demonstration that spiked systemic administrations of young plasma improve age-impaired autophagy levels in the hippocampus [25] [26] [27] [28] and that the rejuvenating effects of young plasma injections on memory decline during aging are abrogated after the downregulation of hippocampal autophagy. These findings favor the notion that young blood factors reverse age-dependent alterations in memory by restoring autophagy levels in old hippocampi. They also suggest a prominent role for brain autophagy in mediating the communication between systemic milieu and hippocampal neurons for fostering cognitive fitness throughout life.
Although the mechanisms involved in the age-associated decline of autophagy are still being elucidated, our results suggest that the loss or decrease of young circulating factors in plasma contribute to this decline. Among these factors, Ocn, a bone-derived hormone that passes through the blood-brain barrier and influences hippocampal-dependent memory by binding to the G-coupled receptor Gpr158 in hippocampal neurons [28, [38] [39] [40] [41] , has been recently identified as a necessary component of young plasma for improving the deleterious effects of aging on learning and memory. We demonstrate here that Ocn injections in aged mice are sufficient to significantly ameliorate age-impaired autophagy in old hippocampi, requiring autophagy to mediate its beneficial effect on age-related cognitive decline. Whereas the role of autophagy as a mediator in the dialogue between peripheral organs is well described (e.g., pancreatic hormones in the regulation of liver autophagy), this study highlights for the first time a key role for autophagy in shaping the communication between peripheral tissues and the brain. The identification of Ocn as a novel hormonal inducer of autophagy does not exclude the contribution of other systemic circulating factors in fostering hippocampal memory capacities via induction of autophagy, which is also suggested by the partial rescue of hippocampal autophagy levels observed after systemic injections of young plasma immunodepleted for Ocn. However, this provides new insights into the larger role of autophagy in the mediation of hormonal actions on cognitive function.
In summary, we show here that autophagy plays a key role in promoting the formation of new memory in hippocampal neurons by modulating structural and functional activity-dependent synaptic plasticity. Impaired hippocampal autophagy activity is observed during aging and leads to memory decline, and restoring autophagy levels in old hippocampi is sufficient to reverse age-related memory deficits. Autophagy promotes the effects of systemic administrations of young plasma on brain cognitive fitness. Among these factors, we identified Ocn has a novel anti-geronic hormonal inducer of autophagy in hippocampal neurons, highlighting the role of autophagy in mediating hormonal regulation of neuronal and behavioral functions in the brain. Altogether, these findings underlie novel physiological functions for autophagy in the brain for promoting the adaptive responses of the hippocampal neurons to novel stimulations and systemic factors and may guide the development of treatments for aged-memory decline in aging populations.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: 
EXPERIMENTAL MODEL AND SUBJECT DETAILS Animals
All experiments were performed on C57BL/6J WT male mice (obtained from Janvier Laboratory, Le Genest St Isle, France). All mice were 3 or 16 months of age at the start of experiments. For all experiments, we used littermates as controls. Upon arrival, mice were housed at least 2 weeks before any behavioral or molecular testing. Mice were housed 5 animals per cage in polycarbonate cages (35.5 3 18 3 12.5 cm), under a 12 hours light/dark cycle with ad libitum access to food and water prior to experimentation. All behavioral experiments were performed between 10AM and 5PM. In all experiments, animals were randomly assigned to treatment groups. Group sizes were determined after performing a power calculation to lead to an 80% chance of detecting a significant difference (p % 0.05). All behavioral experiments were performed in accordance with the European Communities for Experimental animal use (2010/ 63/EU) and local ethical committee review procedures and protocols (APAFIS -13939 -201803071644868v1). Semiquantitative RT-PCR Brain tissues were immediately flash-frozen after dissection and total RNA was isolated with TRIzol Reagent using a homogenizer. Single-strand cDNA was synthesized from total RNA (2 mg) by using SuperScript II Reverse Transcriptase. qRT-PCR was performed using iTAQ SYBR Green (BioRad). The following primers were used: Becn 1 primers (5 0 -ATGGAGGGGTCTAAGGCGTC-3 0 and 5 0 -TCCTCTCCTGAGTTAGCCTCT-3 0 ), Atg5 primers (5 0 -TGTGCTTCGAGATGTGTGGTT-3 0 and 5 0 -GTCAAATAGCTGACTCTTGG CAA-3 0 ), Vps34 primers (5 0 -CCTGGACATCAACGT GCAG-3 0 and 5 0 -TGTCTCTTGGTATAGCCCAGAAA-3 0 ), FIP200 primers (5 0 -GAC ACTG AGCTAACTGTGCAA-3 0 and 5 0 -GCGCTGTAAGTACACACTCTT C-3 0 ), and ATG12 primers (5 0 -TTCGGTTGCAGT TTCGC C-3 0 and 5 0 -CCATGCCTGTGATTTGCAGTA-3 0 ).
METHOD DETAILS
Western blot analysis
Stereotaxic surgery
Mice were anesthetized by intraperitoneal injection of ketamine hydrochloride (20mg/ml BW) (1000 Virbac) and xylazine (100mg/ml BW) (Rompun 2%; Bayer) and placed in a stereotaxic frame (900SL-KOPF). Ophthalmic eye ointment was applied to the cornea to prevent desiccation during surgery. The area around the incision was trimmed and V etoquinol was applied. All drugs were injected bilaterally into the dorsal hippocampi using the following coordinates (from Bregma, Paxinos and Franklin, 2008): X = +/À1.4 mm, Y = 2.0 mm and Z = À1.33 mm. A 1 mL volume of either AAV or drugs was injected stereotaxically over 4 min (injection rate: 0.25 mL per min). To limit reflux along the injection track, the needle was maintained in situ for 4 min between each 1 mL injection.
Pharmacological modulation of autophagy
For pharmacological hippocampal induction of autophagy, we performed intra-hippocampal injections of either vehicle (PBS), 1 mg TAT-Scramble (dissolved in PBS) or 1 mg TAT-Beclin 1 (dissolved in PBS). The Tat-Beclin 1 (YGRKKRRQRRRGGTNVFNAT FEIWHDGEFGT) consisted of 11 amino acids of the TAT protein transduction domain (PTD) at the N terminus, a GG linker to increase flexibility, and 18 amino acids derived from Beclin 1, amino acids 267-284 containing 3 substitutions: H275E, S279D, Q281E. Control peptide, TAT-Scramble (YGRKKRRQRRRGGV GNDFFINHETTGFATEW), consisted of the TAT protein transduction domain, a GG linker, and a scrambled version of the C-terminal 18 amino acids from Tat-Beclin 1. For pharmacological hippocampal inhibition of autophagy formation, we performed intra-hippocampal injections of either Spautin-1 (5 mg (SML0440: Sigma) dissolved in DMSO/NaCl) or vehicle (DMSO/NaCl). For pharmacological hippocampal inhibition of the late stage of the autophagic pathway, we performed stereotactic injections of either 100ng Leupeptin (L2023: Sigma) (dissolved in PBS), 50 mg Chloroquine (C6628: Sigma) (dissolved in PBS) or vehicle (PBS). All drugs were infused in a volume of 1 mL (bilaterally) in the dorsal hippocampus either 12 hours before training phase or 12 hours before the testing phase for the NOR, CFC or OLM behavioral tasks. For brain collection hippocampal stereotactic injections were performed either 12 or 36 hours before sacrifice.
Adeno-associated viruses expressing shRNA
Adeno-associated viruses (AAV) expressing shRNA were purchased from Vector Biosystems Inc (Malvern PA). shRNAs specific to Beclin 1 (Becn 1) (AAV9-GFP-U6-mBECN1-shRNA), FiP200 (AAV9-GFP-U6-M-RB1CC1-shRNA), ATG12 (AAV9-GFP-U6-m-ATG12-shRNA) or scrambled non-targeting negative control (AAV-GFP-U6-scrmb-shRNA) were injected in a volume of 1 mL (bilaterally), 3 weeks prior to behavioral tests or brain tissue collection. The AAV titers were between 2.8 and 4.3 3 10 13 GC/ml. AAV expressing shRNAmir targeting Beclin 1 (Becn 1) specifically in neurons (AAV9-eSYN-GFP-Beclin 1-shRNAmir) were purchased from Vector Biosystems Inc (Malvern PA). Beclin 1 shRNAmir is driven by the eSYN promoter, a hybrid promoter consisting of the 0,45Kb human Synapsin 1 promoter fragment (hSYN1). AAV-eSYN-GFP-shRNA155mir was used as control. The AAV titers were between 5.3 and 5.9 3 10 13 GC/ml.
Behavioral tests Novel object recognition paradigm (NOR)
The behavior sessions were recorded with a video camera. The testing arena consisted on two plastic boxes (60 3 40 3 32 cm). Mice could not contact or see each other during the exposures. The light intensity was equal in all parts of the arena. Two different objects were used, available in triplicate: (A) a blue ceramic pot (diameter 6.5 cm, maximal height 7.5 cm) and (B) a clear/plastic funnel (diameter 8.5 cm, maximal height 8.5 cm). The objects elicited equal levels of exploration as determined in pilot experiments and training phase. Mice were transported a short distance from the holding mouse facility to the testing room in their home cages and left undisturbed for at least two hours before the beginning of the test. Mice were always placed in the center of the arena at the start of each exposure.
The NOR paradigm consists of three phases over 3 days. On day 1 (habituation phase): mice were given 5 min to explore the arena, without any objects and were then taken back to their home cage or for stereotactic surgery. On day 2 (training phase): mice were allowed to explore, for 10 min, two identical objects arranged in a symmetric opposite position from the center of the arena and were then transported to their home cage. On day 3 (testing phase): mice were given 15 minutes to explore two objects: a familiar object and a novel one, in the same arena, keeping the same object localization. The object that serves as a novel object (A or B), as well as the left/right localization of the objects were counterbalanced within each group. Between exposures, arenas were cleaned with phagosphore, and the bedding replaced. The following behaviors were considered as exploration of the objects: sniffing or touching the object with the nose or with the front legs or directing the nose to the object at a distance % 1 cm. Investigation was not scored if the mouse was on top of the object or completely immobile. The preference index (time spent exploring the new object / the total time spent exploring both objects) and the discrimination index (time spent exploring the new object -time spent exploring the familiar object) / (total time spent exploring both objects) were calculated. As control, preference index for the (right versus left) object location or for the object A versus B during the training phase of the NOR was measured in all groups of mice exposed to the test. Behavior was scored on videos by two observers blind to treatment and the total exploration time of the objects was quantified during the training and testing phases.
Object location memory test (OLM)
For the object location memory task, all procedures were identical to the NOR except that during the testing phase, rather than presenting a novel object, mice encountered both familiar objects, with one object located in a different place in the arena. The time and frequency of exploration of the novel/relocated object is measured as an index of memory. Behavior was scored on videos by two observers blind to treatment and the total exploration time of the objects was quantified in the training and testing phases.
3-foot shock contextual fear conditioning (CFC)
Mice were left undisturbed for at least two hours before the beginning of the test. The conditioning chambers were obtained from Bioseb (France). Each chamber was located inside a larger, insulated plastic cabinet that provided protection from outside light and noise (67 3 55 3 50 cm, Bioseb, France), and mice were tested individually in the conditioning boxes. Floors of the chamber consisted of 27 stainless steel bars wired to a shock generator with scrambler for the delivery of foot shock. Signal generated by the mice movements was recorded and analyzed through a high sensitivity weight transducer system. The analog signal was transmitted to the Freezing software module through the load cell unit for recording purposes and analysis of time active / time immobile (Freezing) was performed.
The CFC procedure took place over two consecutive days. On day 1 (training): mice were placed in the conditioning chamber, and received 3 foot-shocks (1 s, 0.5 mA), which were administrated at 60, 120 and 180 s after the animals were placed in the chamber. On day 2 (testing): contextual fear memory was assessed 24 hours after training by returning the mice to the conditioning chamber and measuring freezing behavior during a 4 min retention test. Freezing behavior was considered to occur if the animals froze for a period of at least two seconds. Freezing was scored and analyzed automatically using Packwin 2.0 software (Bioseb, France) and analyzed by two observers blind to mouse treatment or AAV-infections. Morris Water Maze (MWM) Animals were transported a short distance from the holding mouse facility to the testing room in their home cages and left undisturbed for at least one hour prior the first trial. Morris water maze (MWM) with an automatic tracking system was employed for assessing spatial learning and memory. The apparatus was a white circular swimming pool (diameter: 200 cm, walls: 60 cm high), which was located in a room with various distal cues. The pool was filled with water (depth: 50 cm) maintained at 22 C ± 1 C, which was made opaque by the addition of a nontoxic white paint. A 12 cm round platform was hidden 1.0 cm below the water surface. The maze was virtually divided into four arbitrary, equally spaced quadrants delineated by the cardinal points north (N), east (E), south (S), and west (W). The pool was located in a brightly lit room. Extra maze geometric and high-contrast cues were mounted on the walls of the swimming pool with the ceiling providing illumination. Each daily trial consisted of four swimming trials, in which each mouse was placed in the pool facing the wall of the tank and allowing the animal to swim to the platform before 120 s had elapsed. A trial terminated when the animal reached the platform, where it remained for 5 s. Mice were removed and placed back in their home cages for a 5 min inter-trial interval. To prevent hypothermia, the animals were gently dried with a paper towel between and after the trials. The starting point differed at each trial, and different sequences of release points were used from day to day. Animal movements were recorded using ANY-maze (Stoelting Co.) to calculate parameters of the performance of mice. Open Field Tests (OFT) Mice were transported a short distance from the holding facility to the testing room in their home cages and left there undisturbed for at least two hours. Each animal was placed in a 43 3 43 cm open field chamber, and tested for 30 min. Mice were placed individually into the center of the open-field arena and allowed to explore freely. Mice were monitored throughout each test session by infrared light beam activity monitor using actiMot2 Software (PhenoMaster Software, TSE System, Germany). The overall motor activity was quantified as the total distance traveled. Anxiety was also quantified by measuring the percentage of the time and distance spent in the center versus periphery of the open-field chamber.
Rotarod test
Motor function and motor learning was evaluated using an accelerating rotarod (Rota-rod/RS, Bioseb, France). On day one, mice received 2 habituation trials of 120 s (acceleration of from 4 to 20 rpm in 120 s) followed by 3 training trials of 5 min (acceleration of from 4 to 30 rpm in 5 min). On day 2, mice received 5 additional training trials. The maximum time reached in each trial was the dependent measure.
Memory-related stimulation procedures
Animals were either exposed to CFC or MWM to induce memory-related stimulations adapted from [21, 25] . For the CFC, we used one-or four-days for the training phase. For the one-day training, mice were placed into the conditioning chamber, received three shocks at 60, 120 and 180 s (1 s, 0.5 mA), and were removed 60 s following the last shock and returned to their home cages. For the four-day training, this procedure was repeated four times but at a shock intensity of 0.3 mA. Contextual fear memory was assessed 24 hours following training by returning the mice to the same conditioning chamber and measuring the freezing behavior during a 4 min retention test. For the MWM, the mice were subjected to the normal procedure (described above) for 1 day or 5 successive days. On the last day of stimulation, the mice were sacrificed 1 hour after the last exposition to CFC or MWM task.
Restraint procedure
The restraint stress group was immobilized for 30 min by a restrainer that was made of transparent acrylic, forming a cylinder (cylinder diameter of 33 mm 3 height of 115 mm), which restricted their movement completely. The mice were then euthanized 1 hour after the restraint stress (as we did after exposing mice to MWM or CFC). The control group was handled as the exposed group but sacrificed without restraint treatment. Then, mouse hippocampi were dissected, snap frozen and lysed in RIPA lysis buffer to perform western blot analysis to evaluate Beclin 1, p62, LC3-I and -II abundances.
Plasma collection and intravenously injection
Pooled mouse blood was collected from 80 young (8-week-old) and 20 aged (16-month-old) mice by intra-cardial bleed at the time of euthanasia. Plasma was prepared from blood collected with EDTA into Capiject T-MQK tubes followed by centrifugation at 1,000g. All plasma aliquots were stored at À80 C until use. Before administration, plasma was dialyzed using 3.5-kDa Maxi D-tube dialyzers (71508-3, Novagen) in PBS to remove EDTA. 16-month-old mice were injected with young, old or Ocn-immunodepleted isolated
